Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Transformative Impact of AR and VR Technologies in Healthcare Amidst the COVID-19 Pandemic

    Jan 30, 2024, 08:50 AM by
    The COVID-19 pandemic has acted as a catalyst for the integration of AR and VR technologies in the healthcare industry. From training healthcare professionals to addressing staff shortages, educating patients, and facilitating treatment and rehabilitation, these immersive technologies have proven their worth in navigating the complexities of the ongoing global health crisis. As the world continues to grapple with the challenges posed by the pandemic, the role of AR and VR in healthcare is likely to evolve and expand, ushering in a new era of innovation and resilience in the face of health emergencies.
    Full story
  • Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service

    Jan 30, 2024, 08:50 AM by
    Full story
  • Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability

    Jan 30, 2024, 08:50 AM by
    Full story
  • Follow the Money: Biomedical Research Program, Depression Treatment Implant Device, AI Advancements, More

    Jan 30, 2024, 01:00 AM by User Not Found
    Bio-IT World | The University of New England has received an award from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence to be named the UNE Center for Cell Signaling Research; Motif Neurotech has secured a Series A financing for the development of lead product, DOT microstimulator; Ex-Nvidia exec launches and intends to further develop AI platform RagaAI; more.
    Full story
  • Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release

    Jan 29, 2024, 08:34 AM by
    Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare.
    Full story
  • CD BioSciences Releases Analysis of Marine Organisms to Drive Marine Bioresearch Forward

    Jan 29, 2024, 08:34 AM by
    CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.
    Full story
  • Creative Proteomics Amplifies Its Services with High-precision Amino Acid Analysis

    Jan 29, 2024, 08:34 AM by
    Full story
  • Creative Proteomics Offers Advanced Steroids Analysis Service for Medical Industry

    Jan 29, 2024, 08:34 AM by
    Full story
  • Creative Proteomics Bolsters Its Position in Biomarker Discovery with N-Glycan and O-Glycan Profiling Services

    Jan 29, 2024, 08:34 AM by
    Full story
  • Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston

    Jan 26, 2024, 08:48 AM by
    Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.
    Full story
  • Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

    Jan 26, 2024, 08:48 AM by
    Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
    Full story
  • Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents

    Jan 26, 2024, 08:48 AM by
    Full story
  • CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy

    Jan 26, 2024, 08:48 AM by
    Full story
  • Alfa Chemistry Announces Ability to Supply Recombinant Human Collagens

    Jan 26, 2024, 08:48 AM by
    Full story
  • MedPharm, Ltd. Expands Senior Leadership Team with New Senior Director of Sales & Marketing

    Jan 26, 2024, 08:48 AM by
    MedPharm, Ltd. is announcing the addition of Daniel Morland to its Senior Leadership Team as Senior Director of Sales & Marketing. Dan has more than 15 years of experience in the pharmaceutical industry and will be based out of the company's Headquarters in Guildford, UK. He will directly oversee MedPharm's global commercial efforts.
    Full story
  • Amerigo Scientific Released A Well-Selection ELISA Kits Featured with Simplicity and Consistency

    Jan 25, 2024, 09:01 AM by
    Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.
    Full story
  • First Health Advisory Adds Distinguished Board to Pilot Cyber Health Growth

    Jan 25, 2024, 09:01 AM by
    Full story
  • Singapore Advanced Therapy Drug Manufacturer GDMC Secures US$21 Million Growth Capital Funding to Expand Global Genetic Medicines Design and Manufacturing Operations

    Jan 25, 2024, 09:01 AM by
    Full story
  • Pharmapack Report Predicts Major Innovation for Inhaled Pulmonary and Intra Nasal Drug Delivery in 2024

    Jan 25, 2024, 09:01 AM by
    Full story
  • London North West University Healthcare NHS Trust Finds Digital Way Forward with PhenoTips' Genomic Health Record

    Jan 25, 2024, 09:01 AM by
    London North West University Healthcare NHS Trust (LNWH) unites multiple geographically distinct hospitals with PhenoTips’ cloud-hosted Genomic Health Record (GHR) to digitize genomics and deliver on "Our Way Forward" 5-year plan.
    Full story
  • «
  • 51
  • 52
  • 53
  • 54 (current)
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy